Officials in Bali say they will continue using AstraZeneca COVID-19 vaccine in the ongoing vaccination program, highlighting that those who have received their first jab have only reported minor side-effects so far.
“We can be sure that there are no major side-effects. The COVID-19 vaccination program will still continue using [vaccines from] AstraZeneca,” I Ketut Suarjaya, Bali Health Agency Chief, said today.
The reported side-effects for residents in Bali have included fever or headaches, and are easily treatable, Suarjaya added.
Some countries are restricting the use of AstraZeneca vaccine after reports of rare blood clots, though experts, including the World Health Organization (WHO), said the benefits of the shot outweigh its potential risks.
In Indonesia, North Sulawesi province suspended the use of AstraZeneca vaccine after receiving reports of side-effects ranging from fever, bone pain, to nausea.
Bali has received 200,000 doses of AstraZeneca vaccine, which is being prioritized for use in designated “green zone” areas in the province — Nusa Dua, Sanur, and Ubud — which are being prepared for potential reopening to foreign tourism.